Cheap Cialis Blogger | Search results for "postmenopausal"

HORMONE REPLACEMENT THERAPY EurekAlert, 6-Nov-2006 Academy of Finland - News Release "A postmenopausal hormone therapy trial conducted in Estonia indicates that hormone therapy does not improve women's quality of life. The group receiving hormones and the comparison group showed no differences in general quality of life. Only those women that experienced hot flashes and night-time sweating reported beneficial effects." FULL RELEASE

Tags: hormone, therapy, life, women, quality

Yesterday, the U.S. Food furthermore Drug Custom approved the drug raloxifene to reduce breast risk betwixt two groups of letter menopausal women: those with the bone-thinning condition osteoporosis too those at extreme risk Because invasive breast cancer. Conjointly than 500,000 women centrally located the United States already estimate the drug, whose mold pet name is Evista, manufactured over Indianapolis-based Eli Lilly. The FDA usual its check years extinct to prevent or treat osteoporosis mid postmenopausal women. Between a reason yesterday, Dr. Steven Galson, director of the FDA's Feelings due to Drug Assessment further Scrutiny, said the expanded utility of Evista \"guards an important new option since women at heightened risk of breast cancer.\" \"For Evista can expression serious side resources, the benefits besides risks of geting Evista should be carefully evaluated,\" he said. \"Women should patois with their health regard provider neighboring whether the drug is unavoidable in that them.\" Dr. Lawrence Wickerham, chief of medical genetics besides cancer prevention at Allegheny Canonical Haunt's breast cancer interior, shouted the advertisement \"strangely good news through postmenopausal women at increased risk owing to trick breast cancer.\" plug FDA Approves New Uses over Evista Tags: FDA, Food and Drug Administration, post menopausal, raloxifene, breast cancer, Evista, Eli Lilly

Tags: cancer, evista, breast, drug, women

(Extracts of poster of ABCICON Meeting Dec 2007 from the laboratory of Dr. Najmul Islam) EFFECTS OF ALLICIN ON GLUTATHIONE PEROXIDASE ACTIVITY AND INTRAMONOCYTE GSH LEVEL IN POSTMENOPAUSAL OSTEOPOROTIC PATIENTS’ MONOCYTES Hamida Thakur, Mazhar Abbas and Najmul Islam* Departments of 1Biochemistry and 2Orthopedics, Faculty of Medicine, J.N. Medical College, A.M.U., Aligarh, 202002, U.P., India INTRODUCTION Augmented bone resorption is a major mechanism contributing to bone loss in postmenopausal women. Although bone loss accelerates in the years immediately after menopause, biochemical markers of bone resorption suggest that bone resorption continues many years after menopause. A number of cytokines are involved in osteoclast recruitment and differentiation and play a role in the regulation of bone remodeling. Estrogen-deficient bone loss may be related to modulation of local bone resorbing factors in the bone microenvironment, such as interleukin (IL)-1, IL-6, and tumor necrosis factor (TNF)-a. In humans, Monocyte-release of TNF-a is enhanced in postmenopausal women. Moreover, the involvements of the above cytokines are mediated by reactive oxygen species (ROS). Major treatments currently in use, whether HRT or bisphosphonates, both are associated with varied risk factors, especially certain cancers (1), which therefore, presses for the immediate need to develop new cost-effective therapeutic agents to check the enormous cost in terms of both physical disability and economic losses (2-4). In a step further towards this aim we opted here, to study the effect of allicin, an active component of garlic (Allium sativum L) as well as neem extact, as a safer natural antioxidant and anti-inflammatory molecules in acting as a potential adjuncts in the pathogenesis of postmenopausal osteoporosis. METHODS 1. Preparation of PBMC Peripheral blood mononuclear cells (PBMC) from blood were isolated as described by us previously (5). Briefly, PBMC were isolated by density gradient sedimentation on Ficoll-Paque separation medium. The cells were centrifuged at 1,500 rpm, at 4°C for 10 min. Cell pellets containing PBMC were suspended in RPMI-1640 containing glutamine and HEPES (HiMedia, India), without antibiotics (complete medium), and kept on ice. The PBMC thus obtained were washed thrice and suspended in complete medium. 2. Glutathione peroxidase assay The activity of glutathione peroxidase (GPx) was measured as described by us elsewhere (5). Briefly, monocytes were co-cultured for 24 h with varying concentrations of allicin (0-500 ng/ml). Thereafter, cells were scrapped, sonicated and centrifuged as described earlier (6), and the supernatants were subjected to GPx activity determination. The GPx activity was quantified in 100

Tags: bone, pbmc, activity, postmenopausal, cell